Skip to content

Hippocampal-Sparing Prophylactic Cranial Irradiation in Small Cell Lung Cancer: A Phase II Clinical Trial

Hippocampal-Sparing Prophylactic Cranial Irradiation in Small Cell Lung Cancer: A Phase II Clinical Trial

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000032209
Enrollment
Unknown
Registered
2020-04-23
Start date
2015-12-01
Completion date
Unknown
Last updated
2020-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

small cell lung cancer

Interventions

Case series:PCI

Sponsors

Cancer Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Recently diagnosed small-cell lung cancer patients, PS score 0-1; 2. No previous radiation treatment of the brain; 3. Head MR or CT examination within 1 month before enrollment showed no metastasis; 4. Women of child-bearing age are tested negative for early pregnancy and agree to use adequate contraception during treatment; 5. The patient has enough understanding and education to understand the content of informed consent.

Exclusion criteria

Exclusion criteria: 1. The patient had previously received head and neck radiotherapy, including stereotactic radiotherapy; 2. There were brain metastasis, ipsilateral lung metastasis and malignant pleural effusion confirmed by imaging; 3. It is planned to apply chemotherapy or targeted drug therapy together with cerebral prophylaxis irradiation; 4. Having a second primary cancer or malignancy in the past five years; 5. Epilepsy patients requiring long-term treatment; 6. Mental illness that affects cognitive function.

Design outcomes

Primary

MeasureTime frame
Brain metastasis rate;

Secondary

MeasureTime frame
Overall survival;Progression-free survival;Hopkins Verbal Learning Test, HVLT;toxicity >=2 grade;

Countries

China

Contacts

Public ContactZhou Zongmei

Cancer Hospital, Chinese Academy of Medical Sciences

zhouzongmei2013@163.com+86 13801389769

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026